AR103801A1 - Formas cristalinas de un compuesto de pirrolopiridina - Google Patents

Formas cristalinas de un compuesto de pirrolopiridina

Info

Publication number
AR103801A1
AR103801A1 ARP160100511A ARP160100511A AR103801A1 AR 103801 A1 AR103801 A1 AR 103801A1 AR P160100511 A ARP160100511 A AR P160100511A AR P160100511 A ARP160100511 A AR P160100511A AR 103801 A1 AR103801 A1 AR 103801A1
Authority
AR
Argentina
Prior art keywords
compound
pirrolopiridine
crystal forms
aminopiperidin
cyclopropanecarboxamide
Prior art date
Application number
ARP160100511A
Other languages
English (en)
Spanish (es)
Original Assignee
Genentech Inc
Array Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55521844&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR103801(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc, Array Biopharma Inc filed Critical Genentech Inc
Publication of AR103801A1 publication Critical patent/AR103801A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
ARP160100511A 2015-02-26 2016-02-26 Formas cristalinas de un compuesto de pirrolopiridina AR103801A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562121396P 2015-02-26 2015-02-26

Publications (1)

Publication Number Publication Date
AR103801A1 true AR103801A1 (es) 2017-06-07

Family

ID=55521844

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160100511A AR103801A1 (es) 2015-02-26 2016-02-26 Formas cristalinas de un compuesto de pirrolopiridina

Country Status (21)

Country Link
US (2) US20160251350A1 (cg-RX-API-DMAC10.html)
EP (1) EP3262042A1 (cg-RX-API-DMAC10.html)
JP (1) JP2018506562A (cg-RX-API-DMAC10.html)
KR (1) KR20170118762A (cg-RX-API-DMAC10.html)
CN (1) CN107406447A (cg-RX-API-DMAC10.html)
AR (1) AR103801A1 (cg-RX-API-DMAC10.html)
AU (1) AU2016225070A1 (cg-RX-API-DMAC10.html)
BR (1) BR112017018230A2 (cg-RX-API-DMAC10.html)
CA (1) CA2976665A1 (cg-RX-API-DMAC10.html)
CL (1) CL2017002180A1 (cg-RX-API-DMAC10.html)
CO (1) CO2017009662A2 (cg-RX-API-DMAC10.html)
CR (1) CR20170439A (cg-RX-API-DMAC10.html)
HK (1) HK1246786A1 (cg-RX-API-DMAC10.html)
IL (1) IL254115A0 (cg-RX-API-DMAC10.html)
MA (1) MA41599A (cg-RX-API-DMAC10.html)
MX (1) MX2017010888A (cg-RX-API-DMAC10.html)
PE (1) PE20171327A1 (cg-RX-API-DMAC10.html)
PH (1) PH12017501532A1 (cg-RX-API-DMAC10.html)
RU (1) RU2017133093A (cg-RX-API-DMAC10.html)
SG (1) SG11201706824TA (cg-RX-API-DMAC10.html)
WO (1) WO2016138458A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102405199B1 (ko) * 2019-01-29 2022-06-02 후야 바이오사이언스 인터내셔널 엘엘씨 설카딘 염
US12559463B2 (en) 2019-02-12 2026-02-24 Impact Biomedicines Inc. Crystalline forms of a JAK2 inhibitor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
CL2009001152A1 (es) * 2008-05-13 2009-10-16 Array Biopharma Inc Compuestos derivados de n-(4-(cicloalquilo nitrogenado-1-il)-1h-pirrolo[2,3-b]piridin-3-il)amida, inhibidores de cinasa; proceso de preparacion; composicion farmaceutica; y su uso para el tratamiento de una enfermedad proliferativa.
US8481557B2 (en) * 2009-04-11 2013-07-09 Array Biopharma Inc. Method of treatment using checkpoint kinase 1 inhibitors
CN108721284A (zh) * 2010-11-16 2018-11-02 阵列生物制药公司 检测点激酶1抑制剂和wee1激酶抑制剂的组合
CA2921956C (en) * 2013-08-22 2021-10-19 Genentech, Inc. Process for preparing (r)-5-bromo-4-(3-amino)piperidin-1-yl)-3-(cyclopropanecarboxamido)-1h-pyrrolo[2,3-b]pyridine
WO2015027090A1 (en) * 2013-08-22 2015-02-26 Genentech, Inc. Intermediates and processes for preparing compounds

Also Published As

Publication number Publication date
HK1246786A1 (zh) 2018-09-14
CN107406447A (zh) 2017-11-28
BR112017018230A2 (pt) 2018-04-17
CL2017002180A1 (es) 2018-03-16
IL254115A0 (en) 2017-10-31
KR20170118762A (ko) 2017-10-25
CR20170439A (es) 2018-01-08
PE20171327A1 (es) 2017-09-12
RU2017133093A (ru) 2019-03-26
EP3262042A1 (en) 2018-01-03
WO2016138458A1 (en) 2016-09-01
AU2016225070A1 (en) 2017-09-07
US20180282324A1 (en) 2018-10-04
US20160251350A1 (en) 2016-09-01
RU2017133093A3 (cg-RX-API-DMAC10.html) 2019-08-23
PH12017501532A1 (en) 2018-02-05
CA2976665A1 (en) 2016-09-01
MA41599A (fr) 2018-01-02
JP2018506562A (ja) 2018-03-08
CO2017009662A2 (es) 2018-02-28
MX2017010888A (es) 2017-12-15
SG11201706824TA (en) 2017-09-28

Similar Documents

Publication Publication Date Title
CL2017000902A1 (es) Dihidropirrolopiridinas inhibidoras de ror-gamma
SI3494115T1 (sl) Derivati N-(fenilsulfonil)benzamida kot BCL-2 inhibitorji
DK3870574T3 (da) Aminopyridin/pyrazinderivater som ctps1-inhibitorer
DK3529241T3 (da) Pireridinderivater som inhibitorer af ubiquitin-specifik protease 7
DK3768674T3 (da) Aminopyrimidinderivater som ctps1-hæmmere
MA39749A (fr) Dérivés de pipéridine-dione
AR096758A1 (es) Inhibidores cristalinos de bromodominios
CR20140332A (es) Inhibidores de bromodominios
MX380810B (es) Sondas para la proyección de imagen de la proteína huntingtina.
DK3385262T3 (da) 4-(3h-indol-5-yl)-n-(pyridin-2-yl)pyrimidin-2-aminderivater som proteinkinaseinhibitorer, fremstillingsfremgangsmåde og medicinsk anvendelse deraf
EA201790892A1 (ru) Кристаллические формы 5-хлор-n4-[2-(диметилфосфорил)фенил]-n2-{2-метокси-4-[4-(4-метилпиперазин-1-ил)пиперидин-1-ил]}пиримидин-2,4-диамина
DK3687996T3 (da) Salte af pyrrolotriazinderivater anvendelige som tam-inhibitorer
DOP2017000178A (es) Inhibidores selectivos de bace1
DK3412672T3 (da) Krystalform A af 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-D]pyrimidin-4-amin som TLR7-agonist, fremstillingsfremgangsmåde og anvendelse deraf
WO2014153495A3 (en) Novel stat3 inhibitors
NI201500139A (es) Formas cristalinas de inhibidores de tirosina cinasa y sus sales
CL2019001804A1 (es) Activador de nrf2.
MX386798B (es) Sondas para la proyección de imagen de la proteína huntingtina.
DK3797107T3 (da) Heterokondenserede pyridonforbindelser og anvendelse deraf som idh- hæmmere
CO2020006206A2 (es) Polimorfos y formas sólidas de un compuesto de pirimidinilamino-pirazol y métodos de producción
AR104935A1 (es) Formas cristalinas de un inhibidor de histona deacetilasa
CL2017002180A1 (es) Formas cristalinas de un compuesto de pirrolopiridina
IL283656A (en) New crystalline forms of a mcl-1 inhibitor, a process for their preparation and pharmaceutical compositions containing them
UY36393A (es) Síntesis de inhibidor de pi3k y sales del mismo
UY36958A (es) Compuestos para administración intracelular

Legal Events

Date Code Title Description
FB Suspension of granting procedure